Securities code: Fujian Aonong Biological Technology Group Incorporation Limited(603363) securities abbreviation: Fujian Aonong Biological Technology Group Incorporation Limited(603363) Announcement No.: 2022079
Convertible bond Code: 113620 convertible bond abbreviation: aonong convertible bond
Fujian Aonong Biological Technology Group Incorporation Limited(603363) some directors, supervisors and senior executives terminated the share reduction plan in advance and announced the results of share reduction through centralized bidding
The board of directors, all directors and relevant shareholders of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents. Important content tips:
Basic information about the shareholding of Dong Jiangao
As of the date of this announcement, Mr. Wu Jun, Mr. Ye Junbiao, Mr. Zhang Jingxue, Mr. Hou Haofeng and Mr. Huang Zesen, some directors, supervisors and senior managers of Fujian Aonong Biological Technology Group Incorporation Limited(603363) (hereinafter referred to as “the company”), have directly held 8807727 shares of the company, accounting for 1.0674% of the total share capital of the company. (among them, Mr. Wu Jun, Mr. Ye Junbiao, Mr. Hou Haofeng and Mr. Huang Zesen have 409500, 312000, 312000 and 189000 restricted shares respectively, which have been transferred to the company’s special securities account for repurchase due to the company’s repurchase cancellation, and will be completed on May 24, 2022)
Implementation results of centralized bidding reduction plan
According to the announcement on share reduction plan of some directors, supervisors and senior executives through centralized bidding (Announcement No.: 2022046) disclosed by the company on April 22, 2022, Mr. Wu Jun, Mr. Ye Junbiao, Mr. Zhang Jingxue, Mr. Hou Haofeng and Mr. Huang Zesen plan to reduce their total shares by no more than 2059300 shares (accounting for 0.2496% of the current total share capital of the company), and the reduction period is from May 19, 2022 to November 18, 2022. As of the disclosure date of this announcement, Mr. Wu Jun, Mr. Ye Junbiao, Mr. Zhang Jingxue, Mr. Hou Haofeng and Mr. Huang Zesen did not reduce their shares of the company by means of centralized bidding trading during the period of this reduction plan, and decided to terminate this reduction plan in advance. 1、 Basic information of the subject of centralized bidding reduction before reduction
Number of shares held
Shareholder name shareholder identity shareholding proportion current shareholding source
(shares)
Wu Jun’s directors, supervisors and senior management: 13650000.1654% obtained by other means: 1365000 personnel shares
Way of obtaining ye Junbiao’s shares: 13280105% of the total number of directors and other supervisors before IPO
Zhang Jingxue director, supervisor and senior management 23895900.2896% obtained before IPO: 2389590 shares
Hou Haofeng, director, supervisor and senior management 20801220.2521% obtained before IPO: 1040122 shares obtained by personnel in other ways: 1040000 shares
Huang Zesen’s directors, supervisors and senior management 6050000.0733% obtained by other means: 605000 shares
Note 1: among the current sources of holding shares, “obtained by other means” refers to shares obtained through restricted equity incentive. October 2020,
The company transferred 0.3 shares per share to all shareholders with capital reserve, and the shares held by the above shareholders include the shares transferred.
Note 2: as of the date of this announcement, among the shares held by the above shareholders, Mr. Wu Jun, Mr. Ye Junbiao, Mr. Hou Haofeng and Mr. Huang Zesen
Mr. has 409500 shares, 312000 shares, 312000 shares and 189000 shares of restricted shares due to the implementation of the company
The cancellation of the purchase has been transferred to the company’s special securities account for repurchase (account number: b882251787), which will be completed on May 24, 2022
The cancellation is completed on the day.
There is no concerted action of the above subjects.
2、 Implementation results of the centralized bidding reduction plan (I) the directors, supervisors and senior executives disclose the implementation results of the centralized bidding reduction plan due to the following matters:
Other circumstances: early termination of share reduction plan
Reduction number reduction ratio reduction price range reduction total amount reduction completed current number of shares current shareholding ratio shareholder name reduction period (yuan / share)
Quantity (stock) case formula (yuan) case quantity (stock) case
Wu Jun 0% 2022 / 5 / 19 ~ centralized bidding 0-0 0 0 unfinished: 13650000.1654% 2022 / 5 / 22 price trading 200000 shares
Ye Junbiao 0 0% 2022 / 5 / 19 ~ centralized bidding 0-0 0 0 not completed: 23680150.2870% 2022 / 5 / 22 price trading 592000 shares
Zhang Jingxue 0 0% 2022 / 5 / 19 ~ centralized bidding 0-0 0 unfinished: 23895900.2896% 2022 / 5 / 22 price trading 597300 shares
Hou Haofeng 0 0% 2022 / 5 / 19 ~ centralized bidding 0-0 0 not completed: 20801220.2521% 2022 / 5 / 22 price trading 520000 shares
Huang Zesen 0 0% 2022 / 5 / 19 ~ centralized bidding 0-0 0 0 unfinished: 6050000.0733% 2022 / 5 / 22 price trading 150000 shares
Note: as of the date of this announcement, among the shares held by the above shareholders, Mr. Wu Jun, Mr. Ye Junbiao, Mr. Hou Haofeng and Mr. Huang Zesen have 409500 shares, 312000 shares, 312000 shares and 189000 restricted shares respectively, which have been transferred to the company’s special securities account for repurchase (account number: b882251787) due to the company’s repurchase cancellation, and will be completed on May 24, 2022.
（2） Whether the actual reduction is consistent with the previously disclosed reduction plan and commitment √ yes □ no (III) whether the reduction time interval expires and whether the reduction has not been implemented √ not implemented □ implemented
During the share reduction plan, Mr. Wu Jun, Mr. Ye Junbiao, Mr. Zhang Jingxue, Mr. Hou Haofeng and Mr. Huang Zesen did not implement the share reduction. Based on their confidence in the company’s future development prospects and the overall judgment of the current market environment, Mr. Wu Jun, Mr. Ye Junbiao, Mr. Zhang Jingxue, Mr. Hou Haofeng and Mr. Huang Zesen decided to terminate the implementation of the share reduction plan in advance. （4） Whether the actual reduction has not reached the minimum reduction quantity (proportion) of the reduction plan √ not reached □ has reached the minimum reduction quantity and proportion are not set in this reduction plan.
（5） Whether to terminate the reduction plan in advance √ yes □ no
Based on the confidence in the company’s future development prospects and the overall judgment of the current market environment, Mr. Wu Jun, Mr. Ye Junbiao, Mr. Zhang Jingxue, Mr. Hou Haofeng, Mr. Huang Zesen and other five people decided to terminate the implementation of this reduction plan in advance.
It is hereby announced.
Fujian Aonong Biological Technology Group Incorporation Limited(603363) board of directors may 23, 2022
